NCT05611554

Effects of an ACT-based Psychological Treatment in Relatives of People With Intellectual Disabilities

Status unknown NA Last updated 1 December 2022

What this trial tests

NA trial testing ACT in Parent-Child Relations in 21 participants. Status unknown.

Timeline

1 December 2021

Primary endpoint
15 July 2022

15 February 2023

Quick facts

Lead sponsor	Universidad Europea de Madrid
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	21
Start date	1 December 2021
Primary completion	15 July 2022
Estimated completion	15 February 2023
Sites	1 location across Spain

Drugs / interventions tested

• ACT — full drug profile →

Conditions studied

• Parent-Child Relations — all drugs for Parent-Child Relations →
• Parental Stress — all drugs for Parental Stress →

Sponsor

Universidad Europea de Madrid

Who can join

18 and older, any sex, with Parent-Child Relations or Parental Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of parental stress in relatives of people with intellectual disabilities

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Third-Generation Behavioural Therapies in the Context of Neurodevelopmental Problems and Intellectual Disabilities: A Randomised Clinical Trial with Parents.
   Lobato D, Montesinos F, Polín E, Cáliz S. · · 2023 · cited 3× · PMID 36901415 · DOI 10.3390/ijerph20054406